Epigenetic silencing of selected hypothalamic neuropeptides in narcolepsy with cataplexy
Proceedings of the National Academy of Sciences · 2023
DOI: 10.1073/pnas.2220911120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2023. Verfasst von Ali Seifinejad und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Faculty of Biology and Medicine, University of Lausanne, 1005, Lausanne, Switzerland. Hauptthemen laut MEDLINE: Cataplexy, Neuropeptides, Narcolepsy. Die Arbeit wurde bisher 65-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Swiss National Science Foundation.
Abstract (Originalsprache)
Narcolepsy with cataplexy is a sleep disorder caused by deficiency in the hypothalamic neuropeptide hypocretin/orexin (HCRT), unanimously believed to result from autoimmune destruction of hypocretin-producing neurons. HCRT deficiency can also occur in secondary forms of narcolepsy and be only temporary, suggesting it can occur without irreversible neuronal loss. The recent discovery that narcolepsy patients also show loss of hypothalamic (corticotropin-releasing hormone) CRH-producing neurons suggests that other mechanisms than cell-specific autoimmune attack, are involved. Here, we identify the HCRT cell-colocalized neuropeptide QRFP as the best marker of HCRT neurons. We show that if HCRT neurons are ablated in mice, in addition to Hcrt, Qrfp transcript is also lost in the lateral hypothalamus, while in mice where only the Hcrt gene is inactivated Qrfp is unchanged. Similarly, postmortem hypothalamic tissues of narcolepsy patients show preserved QRFP expression, suggesting the neurons are present but fail to actively produce HCRT. We show that the promoter of the HCRT gene of patients exhibits hypermethylation at a methylation-sensitive and evolutionary-conserved PAX5:ETS1 transcription factor-binding site, suggesting the gene is subject to transcriptional silencing. We show also that in addition to HCRT, CRH and Dynorphin ( PDYN ) gene promoters, exhibit hypermethylation in the hypothalamus of patients. Altogether, we propose that HCRT , PDYN , and CRH are epigenetically silenced by a hypothalamic assault (inflammation) in narcolepsy patients, without concurrent cell death. Since methylation is reversible, our findings open the prospect of reversing or curing narcolepsy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Sciences, Faculty of Biology and Medicine, University of Lausanne, 1005, Lausanne, Switzerland.
- Sleep-Wake Centre Stichting Epilepsie Instellingen Nederland, 2103SW Heemstede, The Netherlands.
- Department of Neurology, Leiden University Medical Center, 2333ZA Leiden, The Netherlands.
- Netherlands Institute for Neuroscience, An Institute of the Royal Netherlands Academy of Arts and Sciences, Amsterdam 1105 BA, The Netherlands.
- Department of Biochemistry, State University of New York at Buffalo, Buffalo, NY 14260-1660.
- Infinity-Institut Toulousain des Maladies Infectieuses et Inflammatoires, Université de Toulouse, CNRS, INSERM, Université Paul Sabatier, 31059 Toulouse, France.
ORCID-Profile: Mergim Ramosaj, Marie-Laure Possovre, Corinne Pfister, Rolf Fronczek, Lee A Garrett-Sinha, David Frieser, Makoto Honda, Dogan Grepper, Andrea Agnoletto, Christian Iseli, Roland Liblau, Anne Vassalli, Mehdi Tafti
Förderung
- Swiss National Science Foundation
Zitieren
APA
Seifinejad, A., Ramosaj, M., Shan, L., Li, S., Possovre, M. L., Pfister, C., Fronczek, R., Garrett-Sinha, L. A., Frieser, D., Honda, M., Arribat, Y., Grepper, D., Amati, F., Picot, M., Agnoletto, A., Iseli, C., Chartrel, N., Liblau, R., Lammers, G. J., …, & Tafti, M. (2023). Epigenetic silencing of selected hypothalamic neuropeptides in narcolepsy with cataplexy. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2220911120
Vancouver
Seifinejad A, Ramosaj M, Shan L, Li S, Possovre ML, Pfister C, et al. Epigenetic silencing of selected hypothalamic neuropeptides in narcolepsy with cataplexy. Proceedings of the National Academy of Sciences. 2023. doi:10.1073/pnas.2220911120
BibTeX
@article{Seifinejad2023,
author = {Seifinejad, Ali and Ramosaj, Mergim and Shan, Ling and Li, Sha and Possovre, Marie-Laure and Pfister, Corinne and Fronczek, Rolf and Garrett-Sinha, Lee A and Frieser, David and Honda, Makoto and Arribat, Yoan and Grepper, Dogan and Amati, Francesca and Picot, Marie and Agnoletto, Andrea and Iseli, Christian and Chartrel, Nicolas and Liblau, Roland and Lammers, Gert J and Vassalli, Anne and Tafti, Mehdi},
title = {Epigenetic silencing of selected hypothalamic neuropeptides in narcolepsy with cataplexy},
journal = {Proceedings of the National Academy of Sciences},
year = {2023},
doi = {10.1073/pnas.2220911120}
}
EUVIMED